نتایج جستجو برای: biological response modifiers

تعداد نتایج: 1383692  

Journal: :Journal of immunology 2015
Eva-Stina Edholm Leon Grayfer Francisco De Jesús Andino Jacques Robert

Nonclassical MHC class Ib-restricted invariant T (iT) cell subsets are attracting interest because of their potential to regulate immune responses against various pathogens. The biological relevance and evolutionary conservation of iT cells have recently been strengthened by the identification of iT cells (invariant Vα6 [iVα6]) restricted by the nonclassical MHC class Ib molecule XNC10 in the a...

2016
A. L. Silva P. C. Soema B. Slütter F. Ossendorp W. Jiskoot

Among the emerging subunit vaccines are recombinant protein- and synthetic peptide-based vaccine formulations. However, proteins and peptides have a low intrinsic immunogenicity. A common strategy to overcome this is to co-deliver (an) antigen(s) with (an) immune modulator(s) by co-encapsulating them in a particulate delivery system, such as poly(lactic-co-glycolic acid) (PLGA) particles. Parti...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2013
Nobutaka Suzuki Yuko Takimoto Riho Suzuki Takanari Arai Kazuo Uebaba Masuo Nakai Jeffry Michael Strong Harukuni Tokuda

Extract of Lentinula edodes mycelia (LEM) is currently utilized as an oral biological response modifier (BRM) medicine for cancer patients. However, its effectiveness for breast cancer patients with postoperative adjuvant hormone therapy has not yet been scientifically verified. In this study, we investigated the influence of LEM on the quality of life (QOL) and immune response in breast cancer...

Journal: :Infectious disease clinics of North America 2011
Scott J Bergman McKenzie C Ferguson Cathy Santanello

This article explains the rationale for development of interferons as therapeutic agents, and describes commercial products available today. It also provides a summary of studies that have been performed with interferons for use as exogenous biological response modifiers in viral infections. Overall, the best data exist for treatment of viral hepatitis B and C, for which interferons are a corne...

Journal: :Tumori 2010
Vito D'Alessandro Antonio Greco Celeste Clemente Marco Sperandeo Angelo De Cata Concetta Di Micco Evaristo Maiello Gianluigi Vendemiale

Tumor lysis syndrome has been observed in patients with bulky, treatment-sensitive tumors, in particular hematological malignancies, especially after medical treatment (chemotherapy, corticosteroids, radiation, hormonal agents, and biological response modifiers). Tumor lysis syndrome has been observed also in solid malignancies and it very rarely occurs spontaneously. Tumor lysis syndrome-assoc...

Journal: :World journal of clinical oncology 2011
Vaclav Vetvicka

β-glucans belong to a group of biologically active natural compounds called biological response modifiers. These substances represent highly conserved structural components of cell walls in fungi, yeast, grain and seaweed. Despite almost 160 years of intensive research, the exact mechanisms of their action remain unsolved. The significant role of glucans in cancer treatment, infection immunity,...

Journal: :The Yale Journal of Biology and Medicine 1988
J. P. Dutcher S. Wadler P. H. Wiernik

Biological therapy is currently being investigated in the treatment of a number of malignancies. The hypothesis for the use of this therapeutic modality involves an attempt to stimulate an already existent but perhaps suboptimal immune response to foreign protein, including tumor. Immunologic therapy appears to work best against small-volume disease, as indicated from animal studies. This condi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید